Evidence map›Paper›PMID 37514424›Full record

ArticlePolymers2023

Hybrid Coatings for Active Protection against Corrosion of Mg and Its Alloys.

Andrey S Gnedenkov, Sergey L Sinebryukhov, Valeriia S Filonina, Alexander Yu Ustinov, Sergey V Gnedenkov

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Andrey S GnedenkovInstitute of Chemistry FEB RAS, Vladivostok 690022, Russia.ORCID 0000-0002-9822-7849
Sergey L SinebryukhovInstitute of Chemistry FEB RAS, Vladivostok 690022, Russia.ORCID 0000-0002-0963-0557
Valeriia S FiloninaInstitute of Chemistry FEB RAS, Vladivostok 690022, Russia.
Alexander Yu UstinovInstitute of Chemistry FEB RAS, Vladivostok 690022, Russia.
Sergey V GnedenkovInstitute of Chemistry FEB RAS, Vladivostok 690022, Russia.ORCID 0000-0003-1576-8680
Institute of Chemistry, Far Eastern Branch of the Russian Academy of Sciences · RU

Funding

Russian Science Foundation 20-13-00130Russian Science Foundation 21-73-10148
6 · The paper itself

Abstract

A novel approach to surface modification was developed to improve the corrosion performance of biodegradable magnesium alloys. Additively manufactured magnesium samples and Mg-Mn-based magnesium alloys were used in this study. This method involves the combination of plasma electrolytic oxidation to create a porous ceramic-like matrix, followed by treatment with protective biocompatible agents. The most efficient method for the PEO-layer impregnation using sodium oleate and polycaprolactone was selected and optimized. The correlation between the structure, composition, and protective properties of the hybrid coatings was established. The composition of the formed polymer-containing layers was established using XPS and Raman microspectroscopy. The presence of sodium oleate and its distribution across the coating surface was confirmed at the microscale. The corrosion-protection level of the hybrid layers was assessed using potentiodynamic polarization measurements, electrochemical impedance spectroscopy, hydrogen evolution testing, and gravimetry (mass-loss tests)

Indexed as

active corrosion protectioncorrosion inhibitormagnesiummagnesium alloysplasma electrolytic oxidation (PEO)polycaprolactone (PCL)protective coatingsodium oleate

Identifiers

PMID37514424
PMCPMC10384155
OpenAlexW4384341505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.